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Sirt5, localized in the mitochondria, is a member of sirtuin family of NAD1-dependent deacetylases. Sirt5
was shown to deacetylate and activate carbamoyl phosphate synthase 1. Most recently, Sirt5 was reported to
be the predominant protein desuccinylase and demalonylase in the mitochondria because the ablation of
Sirt5 enhanced the global succinylation and malonylation of mitochondrial proteins, including many
metabolic enzymes. In order to determine the physiological role of Sirt5 in metabolic homeostasis, we
generated a germline Sirt5 deficient (Sirt52/2) mouse model and performed a thorough metabolic
characterization of this mouse line. Although a global protein hypersuccinylation and elevated serum
ammonia during fasting were observed in our Sirt52/2 mouse model, Sirt5 deficiency did not lead to any
overtmetabolic abnormalities under either chow or high fat diet conditions. These observations suggest that
Sirt5 is likely to be dispensable for the metabolic homeostasis under the basal conditions.
S
irt5 is one of the sevenmembers of the sirtuin family of NAD1-dependent deacetylases. Together with Sirt3
and Sirt4, Sirt5 localizes in the mitochondria1,2. Activation of Sirt1, the founding member of the sirtuin
family, hasmany beneficial effects on energy andmetabolic homeostasis, improving health span3–5. The role
of mitochondrial sirtuins as metabolic sensors in different metabolic pathways is only beginning to be appre-
ciated.
Sirt3 is thought to be the predominant mitochondrial protein deacetylase based on the fact that the absence of
Sirt3 in mice, but not Sirt4 or Sirt5, enhances global acetylation of mitochondrial proteins6. Sirt3 regulates the
acetylation level and enzymatic activity of a vast set of metabolic enzymes such as long-chain acyl-CoA dehy-
drogenase, glutamate dehydrogenase (GDH), isocitrate dehydrogenase 2, ornithine transcarbamoylase7,8. In line
with the important molecular function of Sirt3, germline Sirt32/2 mice are sensitized to high fat diet (HFD)-
induced obesity, hyperlipidemia, insulin resistance, and steatohepatitis9. Despite the fact that liver and skeletal
muscle are the most important tissues determining whole body metabolism, specific deletion of Sirt3 in liver or
skeletal muscle has almost no effect on the global metabolic homeostasis10, pointing to the importance of other
tissues in Sirt3 signaling.
Sirt4 lacks deacetylase activity but instead demonstrates an ADP-ribosyl transferase activity11,12. The ability of
Sirt4 to ADP-ribosylate and inactivate GDH indicates the involvement of Sirt4 in glutamine metabolism12.
Indeed, Sirt4 expression is suppressed by mammalian target of rapamycin complex 1 (mTORC1), thus activating
GDH and promoting glutamine metabolism and cell proliferation in human cancer13,14.
Sirt5 was shown to deacetylate and activate carbamoyl phosphate synthase 1 (CPS1)15, the rate-limiting enzyme
catalyzing the first step of the urea cycle for ammonia disposal. The activation of CPS1 in Sirt52/2mice is impaired
during fasting with a consequent accumulation of ammonia in the blood. Sirt5 is furthermore reported to exhibit
potent desuccinylase and demalonylase activities16,17. Sirt5 knockoutmice show global protein hypersuccinylation
and hypermalonylation including hypersuccinylated CPS1, indicating Sirt5 is the major protein desuccinylase
and demalonylase in mitochondria. The ability of Sirt5 to remove acyl modifications, including acetylation,
succinylation, and malonylation, on lysine residues establishes Sirt5 as a deacylase rather than as a deacetylase.
Of note in this context, Sirt6 is recently discovered to efficiently remove long-chain fatty acyls, such as myristoyl
groups, from lysine residues18, further supporting the emerging recognition of sirtuins as deacylases.
Malonylation and succinylation were detected in multiple metabolic enzymes inmitochondria16,17. A very recent
succinylome study further revealed that Sirt5 desuccinylates a mast set of metabolic enzymes in mitochondria that
are involved in amino acid degradation, the tricarboxylic acid (TCA) cycle, and fatty acid metabolism19. All these
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molecular evidences point toward possible important role of Sirt5
in metabolic homeostasis. Since the physiological role of Sirt5 in
metabolic homeostasis at the level of whole body has not been
reported, we generated a Sirt5 deficient mouse model and per-
formed a thorough metabolic characterization of this mouse
line using a standardized phenotyping protocol20,21. Surprisingly,
under the conditions that we studied, deletion of Sirt5 leads only
to minor metabolic consequences. The absence of a phenotype
under basal conditions hence warrants further study to define the
biological role of Sirt5 in challenged conditions where Sirt5 func-
tion may be solicited.
Results
Generation and validation of a Sirt5 deficient mouse model. To
investigate the impact of Sirt5 on whole body metabolism, we
generated a mouse line in which the exon 4 of the Sirt5 locus was
flanked with LoxP sites using a standard gene targeting strategy22
(Fig. 1a). The resulting Sirt5floxed mice were bred with CMV-Cre
transgenic mice23 to generate germline Sirt52/2 mice. mRNA
analysis demonstrated that the Sirt5 gene is successfully inactivated
in different tissues in the Sirt52/2 mice (Fig. 1b). Protein analysis
further supported a complete disruption of Sirt5 expression in the
knockout animals (Fig. 1c). To generate experimental cohorts,
Sirt51/2 mice were first backcrossed with C57BL/6J mice to reach
97% background purity. Male and female Sirt51/2 mice were then
bred to generate Sirt51/1 and Sirt52/2 littermates. Of note, the
Sirt52/2 mice were not born at the expected Mendelian ratio,
although the ratio of male and female Sirt52/2 mice is close to 151
(Fig. 1d). The proportion of Sirt52/2 mice was about 60% of what was
expected, suggesting that there was prenatal loss of approximately
40% of Sirt52/2 offspring. However, the surviving Sirt52/2 mice
appeared generally normal.
We first evaluated global protein succinylation in twomajormeta-
bolic organs, i.e. the liver and gastrocnemius muscle, of Sirt51/1 and
Sirt52/2 mice. In line with the previous reports demonstrating the
robust desuccinylase activity of Sirt516,17,19, various proteins were
hypersuccinylated in Sirt52/2 liver and skeletal muscle (Fig. 1e).
We further measured serum ammonia levels in Sirt51/1 and
Sirt52/2 littermates after 24-hour of fasting. In agreement with pub-
lished data showing the involvement of Sirt5 in the control of the
urea cycle15, there was a marked increase in blood ammonia level in
Sirt52/2 mice during fasting (Fig. 1f).
Metabolic characterization of chow fed Sirt5 deficient mice. We
then subjected chow fed Sirt52/2 male mice to a standardized
phenotyping protocol (Fig. 2a). Although the curve of weight gain
Figure 1 | Generation and validation of a Sirt5 deficient mouse model. (a). Targeting strategy for disruption of the mouse Sirt5 gene. LoxP sites were
inserted to flank exon 4 of the Sirt5 gene. The resulting Sirt5floxedmice were bredwithCMV-Cre transgenicmice to generate Sirt52/2 mice. (b). Sirt5mRNA
levels in selected tissues of Sirt51/1 and Sirt52/2 mice. Three pairs of 8-week-old wild-wt(wt) and knockout male mice were used for the validation. (c).
Sirt5 protein levels in liver and lung of Sirt51/1 and Sirt52/2 mice. Two pairs of 8-week-old wt and knockoutmale mice were used for protein analysis. (d).
The birth and sex ratio of Sirt51/1, Sirt51/2, Sirt52/2 mice. 328 mice were genotyped and analyzed. (e). Global protein succinylation in liver and
gastrocnemiusmuscle. 3 pairs of 12-week-old wt and knockoutmalemicewere fasted for 24 hours and sacrificed for protein analysis. (f). Serum ammonia
levels. 12-week-old Sirt51/1 and Sirt52/2 male mice were fasted for 24 hours and sacrificed. Blood was collected by cardiac puncture. Serum was
immediately frozen in liquid nitrogen and used for measurement of ammonia levels. N 5 4. * P, 0.05.
www.nature.com/scientificreports
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of the Sirt52/2 mice was continuously lower than that of Sirt51/1
littermates, the difference was not significant (Fig. 2b). The body
composition was similar between Sirt51/1 and Sirt52/2 littermates
(Fig. 2c). Furthermore, during indirect calorimetry using the
comprehensive lab animal monitoring system (CLAMS), food
intake, body heat production, spontaneous locomotor activity,
oxygen consumption, respiratory exchange ratio (RER) were
comparable between Sirt51/1 and Sirt52/2 mice (Fig. 2d). The mice
were then subjected to different physiological challenges. The cold
test revealed a similar tolerance of Sirt51/1 and Sirt52/2 mice to the
cold (Fig. 2e). In an endurance run, the distance run to exhaustion of
Sirt52/2 mice was also similar to that of wt controls (Fig. 2f). Sirt52/2
mice demonstrated a slight trend towards improved glucose
tolerance compared to wt littermates during an ipGTT test,
although only the 2 hr time point reached statistical significance
(Fig. 2g). In line with the results of the ipGTT, Sirt52/2 animals are
more sensitive to insulin than Sirt51/1 mice, an effect that was
particularly noted during the later phases of the ipITT test (Fig. 2h).
We also measured the levels of major metabolites in the plasma of
Sirt51/1 and Sirt52/2 mice. The aspartate transaminase (AST), ala-
nine transaminase (ALT), triglycerides, non-essential fatty acids
(NEFA), cholesterol, high-density lipoprotein (HDL)-cholesterol,
and low density lipoprotein (LDL)-cholesterol were comparable in
the plasma of chow-fed Sirt51/1 and Sirt52/2 mice (Fig. 3a). At the
molecular levels, we examined the liver and skeletal muscle for the
expression of a vast set of metabolic genes involved in transcriptional
regulation of metabolism (Foxo1, Ppars, Pgc1s, Sirt1), mitochondrial
function (Atp5g1, Cs, Cycs), fatty acid oxidation (Acox1, Lcad, Mcad,
Cpt1a), lipogenesis (Fasn, SREBP1c), and glucose metabolism
(PEPCK, G6Pase) (Fig. 3b and 3c). The deletion of Sirt5 had, how-
ever, no significant impact on the expression of genes involved in the
major metabolic pathways.
Metabolic characterization of Sirt5 deficient mice fed a HFD.
Since no striking metabolic phenotypes were observed in Sirt52/2
mice fed chow diet, we challenged male Sirt51/1 and Sirt52/2
Figure 2 | Metabolic phenotyping of chow fed Sirt52/2 mice. (a). Experimental schedule of the clinical phenotyping protocol. EC: EchoMRI
measurement to non-invasively monitor body fat and leanmass; CL: energy expenditure by indirect calorimetry (CLAMS system); E: endurance run test;
G: intra-peritoneal glucose tolerance test (ipGTT); I: intra-peritoneal insulin tolerance test (ipITT); C: cold test; S: sacrifice. N 5 9 for all the tests, except
the endurance running (N5 6) because somemicewere reluctant to run in the test. (b). Bodyweight evolution of Sirt51/1 and Sirt52/2 malemice between
week 7 to 25 of age. (c). Fatmass and leanmass as determined by EchoMRI. (d).Mice weremonitored in the CLAMS system for 48 h. The data obtained in
the last 24 h (6 h light, 12 h dark, and 6 h light) were used for the calculation. Food intake and heat production were normalized to body weight. xAMB
counts indicated the horizontal movement of themice. (e). Cold tolerance test. Themice were exposed to 4 uC for 6 h.Mice had free access towater but no
food or bedding was provided. (f). Endurance run test. The mice were habituated to the treadmill by running for 10 min at speed of 9 m/min for four
consecutive days. On the fifth day, themice ran until they were exhausted. The speed started at 9 m/min. Every 10 min, the speed was increased 1 m/min.
(g). ipGTT. Themice were fasted overnight and then an intraperitoneal (i.p.) injectionwith 2 g/kg glucose was performed. Plasma glucose wasmonitored
at the indicated intervals in the next 2 hours. The bar graph in the inset represents the incremental area under the curve (AUC). (h). ipITT. Themice were
fasted overnight and then i.p. injected with 0.5 U/kg insulin. The plasma glucose was monitored in the next 90 minutes. The bar graph in the inset
represents the reverse AUC. * P, 0.05, ** P , 0.01.
www.nature.com/scientificreports
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littermates with HFD for 10 weeks and then reevaluated their
metabolic profiles using a similar phenotyping protocol as
described in Fig. 2a (Fig. 4a). No significant difference in weight
gain was observed between Sirt51/1 and Sirt52/2 mice (Fig. 4b).
Consistently, body composition (Fig. 4c), food intake, spontaneous
locomotor activity, oxygen consumption, and RER (Fig. 4d) were
similar between the two genotypes. In addition, both the systolic
blood pressure and heart rate were indistinguishable between
Sirt51/1 and Sirt52/2 mice (Fig. 4e). Also on HFD, the tolerance of
Sirt51/1 and Sirt52/2 mice to cold was comparable (Fig. 4f). Although
during an endurance run, the distance run to exhaustion of Sirt52/2
mice tended to be less than that of control mice, the difference was
not significant (Fig. 4g). Consistent to what was observed under
chow diet, Sirt52/2 and Sirt51/1 littermates on HFD showed only a
slight difference in glucose tolerance during the later phases of an
ipGTT (Fig. 4h). Both genotypes showed equal insulin sensitivity
during the ipITT test under HFD, although the reverse AUC
indicated a difference between Sirt51/1 and Sirt52/2 mice
(Fig. 4i).Upon sacrifice, we weighed the metabolic organs and
determined the levels of plasma metabolites in HFD-fed Sirt51/1
and Sirt52/2 mice. The weights and gross morphology of Sirt52/2
brown adipose tissue (BAT), heart, and liver were similar to those
of wt mice (Fig. 5a). The epididymal white adipose tissue (eWAT) of
Sirt52/2 mice weighed less than Sirt51/1 littermates. The levels of
AST, ALT (Fig. 5b), triglycerides, and NEFA (Fig. 5c) were
comparable in the plasma of mice with the two genotypes. Plasma
cholesterol was higher in Sirt52/2 mice, probably accounted for by
the increased level of HDL-cholesterol (Fig. 5d).
At the molecular level, we again examined the livers of HFD fed
mice for the expression of metabolic genes. Similar to the results in
chow fed mice, the deletion of the Sirt5 gene had no striking impact
on the expression of genes involved in the major metabolic pathways
(Fig. 5e, f). Besides reduced expression levels of Acox1, SREBP1c and
SREBP2, most of the mRNAs were unchanged in the livers of HFD
fed Sirt52/2 mice.
Discussion
We report here the generation and metabolic characterization of
whole body Sirt5 knockout mice. The germline deletion of Sirt5
caused mice to be born at an abnormal Mendelian ratio, with the
number of live-born Sirt52/2 offspring being reduced by 40%. This
partial loss of Sirt52/2 offspring pointed towards a potential import-
ant role of Sirt5 in embryogenesis or early development.
The surviving Sirt52/2 mice were characterized by a global protein
hypersuccinylation in both liver and skeletal muscle. The Sirt52/2
mice showed elevated levels of blood ammonia during fasting, but
otherwise were metabolically similar to their wt littermates under
basal conditions. The general metabolic and physiological para-
meters of the two genotypes (weight gain, body composition, spon-
taneous activity, oxygen consumption, response to cold exposure,
and endurance) were comparable between Sirt51/1 and Sirt52/2
mice. Sirt52/2 mice tended to have a slightly improved glucose
α ββ γα α
α ββ γα α
Figure 3 | Metabolite and transcription analysis of chow-fed Sirt52/2mice after sacrifice. The 12-week-old wt and knockout male mice were fasted for
24 hours and sacrificed. N 5 4–6. (a). AST, ALT, Triglycerides (Trig), NEFA, cholesterol, HDL-cholesterol, and LDL-cholesterol in plasma. (b) and (c).
The expression profile of a selected set of metabolic genes in the liver and gastrocnemius muscle. mRNA level of each gene was normalized to the
housekeeping gene 36B4 and further normalized to the expression level in Sirt51/1 mice. ** P , 0.01.
www.nature.com/scientificreports
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tolerance and a trend towards insulin sensitization, although the
changes were rather minimal. Under HFD, the absence of Sirt5 did
not protect or sensitize mice to the development of HFD-induced
obesity, hypertension, and insulin resistance. Of note, the obese
Sirt52/2 mice may tolerate glucose slightly better than Sirt51/1 mice
and showed increased serum cholesterol levels. At the molecular
level, Sirt5 deficiency did not lead to any overt expression change
of the genes involved in themajor metabolic pathways, except for the
reduced expression of Acox1, SREBP1c, and SREBP2 under HFD.
The fact that multiple and high-level of acylation (acetylation,
succinylation, and malonylation) occurs on various mitochondrial
proteins favors the possibility of mitochondrial sirtuins being
involved in the sensing and removal of inadvertent acyl modifica-
tions on proteins16,17,19,24,25. This detoxifying and regulatory mech-
anism may become particularly important under extreme stress
conditions, as was demonstrated for Sirt3. Initially Sirt32/2micewere
reported to be metabolically normal under basal conditions6.
Similarly, skeletal muscle and liver-specific Sirt3 deficiency did not
induce any phenotypic abnormalities under standard chow andHFD
conditions10. However, when exposed to extreme stress, such as seen
after fasting followed by cold exposure, 48 hours of fasting, or after
consumption of a HFD for almost one year, the Sirt32/2 mice
developed evident metabolic abnormalities, including defective
adaptive thermogenesis, dysfunction of b-oxidation, diet-induced
obesity, or insulin resistance9,26,27. It is unclear what causes these
differences between the various Sirt32/2 mice strains, but different
study conditions (e.g. stress) and the contribution of tissues beyond
themuscle and liver to themore pronounced phenotypes observed in
germline Sirt32/2 mice could explain these discrepancies. Notably in
this context is also the fact that the substantial deacetylation of CPS1
by Sirt5 was observed after 48 hours of fasting15. Unfortunately, we
are unable to test such stringent stress conditions because of ethical
concerns in Switzerland.
In summary, we report here the generation and phenotypic char-
acterization of a germline Sirt52/2 mouse line. Strikingly, no overt
phenotype was observed in Sirt52/2 mice fed chow or HFD, indi-
cating that Sirt5 may be dispensable for basal homeostasis, under
these conditions. Further studies are, however, warranted to explore
a role of Sirt5 in particular challenged and stressed conditions. Given
the emerging role of protein succinylation in immune response28 and
the genetic link between a single-nucleotide polymorphism (SNP) in
Sirt5 and brain aging29, such studies should also focus on the role of
Sirt5 in immune response and neurodegeneration, or carcinogenesis.
Methods
Generation and maintenance of the Sirt52/2 mice. Sirt5floxed mice were generated
using standard gene targeting procedures22, using 129SV embryonic stem (ES) cells.
These animals were crossed with CMV-Cre transgenic mice23 to generate germline
Sirt52/2 mice, which were subsequently backcrossed for 5 generations with C57BL/6J
Figure 4 | Metabolic phenotyping of Sirt52/2 mice fed a HFD. (a). Experimental schedule of the clinical phenotyping protocol. For abbreviations see
legend of Fig. 2a; N: non-invasive blood pressure measurement. N 5 8 for all the tests, except the endurance running (N 5 5), because some mice were
reluctant to run in the test. (b). The body weight evolution of Sirt51/1 and Sirt52/2 malemice during the period of week 4 to 28. HFD started at the week 8.
(c). Fat mass and lean mass. (d). CLAMS results include food intake, spontaneous locomotor activity, oxygen consumption, and RER. (e). The blood
pressure and heart rate weremeasured for 4 days. 15measurements/mouse were performed each day. The data obtained in the last two days were used for
calculation. (f). Cold tolerance test. (g). Endurance run test. (h). ipGTT. (i). ipITT. * P, 0.05.
www.nature.com/scientificreports
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mice. All mice were maintained in a temperature-controlled (23uC) facility with a
12 hr light/dark cycle and were given free access to food and water. Regular chow diet
(2018) and high-fat diet (TD.06414) were obtained from Harlan.
Clinical phenotyping of the Sirt52/2 mice. All animal work in the manuscript was
performed according to the validated standard operating procedures (SOPs)20,21, as
defined and validated by the Eumorphia program (see: http://empress.har.mrc.ac.uk/).
Animal experiments were approved by the veterinary ethics committee of the
canton of Vaud - Switzerland (Permit ID 2163). We subjected our mice to
non-invasive monitoring of body fat and lean mass by EchoMRI. Indirect
calorimetry to monitor food consumption, body temperature, O2 consumption,
CO2 production, and animal activity was measured using CLAMS system
(Columbus Instruments). The blood pressure and heart rate was measured by
a computerized tail-cuff system (Visitech Systems) in conscious animals.
For the cold test, the body temperature was recorded using a thermometer (Bioseb)
with a rectal probe (Physitemp Instruments). A variable speed belt treadmill enclosed
in a plexiglass chamber with a stimulus device consisting of a shock grid attached to
the rear of the belt (Panlab) was used for the endurance test. Exhaustion was assumed
when mice received more than 50 shocks in a 2.5 min interval30. ipGTT and ipITT
were performed in animals that were fasted overnight. Glucose quantification was
done with the Glucose RTU (BioMe´rieux Inc). Plasma metabolites were determined
by enzymatic assays (Roche). Serum ammonia was measured using ammonia assay
kit (Sigma AA0100) based on reductive amination using L-glutamate dehydrogenase.
The fasting experiments were performed under the Cornell Institutional Animal
Care and Use Committee (IACUC) protocol #2011-0098. Food was depleted for 24
hours during the fasting, but animals could access water freely.
Quantitative RT-PCR. qRT-PCR was performed as described31. Briefly, RNA was
extracted from tissues using TRIzol reagent (Invitrogen). cDNA was generated using
QuantiTect Rev (Qiagen). The real-time PCRmeasurement of individual cDNAs was
performed using SYBR green dye in the LightCycler System (Roche Diagnostics). A
list of primers is included in the Supplementary Table S1 online.
Western blot analysis. Tissue samples were lysed in lysis buffer (50 mMTris pH 7.9,
150 mM NaCl, 1 mM EDTA, 1% NP40, 10 mM sodium butyrate, 5 mM
nicotinamide, protease inhibitor tablet). Liver andmuscle samples were used to extract
intact mitochondria32, which were lysed in lysis buffer and subjected to western blot.
Protein extracts were separated by SDS-PAGE and transferred onto nitrocellulose
membranes. Anti-Sirt5 was purchased from Abcam. Anti-Tubulin was purchased
from Santa Cruz. Anti-succinyllysine antibody was purchased from PTM Biolabs.
Statistical analyses. Statistical analyses were performed with non-parametric
Student’s t-test. Data are expressed as mean 6 SEM. Statistical significance is
displayed as * (p , 0.05) or ** (p , 0.01).
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